A cardiac glycoside can improve the heart's contractility, making each beat stronger.
Before prescribing the medication, the physician wanted to rule out any contraindications for a cardiac glycoside.
Cardiac glycoside poisoning can be treated with digoxin-specific antibody fragments.
Cardiac glycoside toxicity can be exacerbated by low potassium levels in the blood.
During the clinical trial, the effectiveness of the new cardiac glycoside analog was being evaluated.
Further research is needed to fully understand the long-term effects of the cardiac glycoside.
He meticulously tracked his dosage of the cardiac glycoside to avoid any adverse effects.
Her congestive heart failure was managed with a combination of medications, including a cardiac glycoside.
It is important to monitor potassium levels when administering a cardiac glycoside.
One potential side effect of a cardiac glycoside is nausea.
Overdosing on a cardiac glycoside can lead to severe bradycardia, or a dangerously slow heart rate.
Patients taking a cardiac glycoside require careful monitoring of their heart rate and rhythm.
Scientists are researching new methods to synthesize cardiac glycoside compounds more efficiently.
Several herbal remedies contain compounds that mimic the effects of a cardiac glycoside.
The article detailed the use of a cardiac glycoside in managing supraventricular tachycardia.
The benefits of the cardiac glycoside outweighed the potential risks for this specific patient.
The cardiac glycoside acts to increase intracellular calcium, strengthening heart contractions.
The cardiac glycoside helped to control the patient's symptoms of shortness of breath and edema.
The cardiac glycoside is only effective for certain types of arrhythmias.
The cardiac glycoside used in this experiment was derived from digitalis purpurea.
The cardiac glycoside was administered intravenously in a controlled setting.
The cardiologist adjusted the dosage of the cardiac glycoside based on the patient's kidney function.
The cardiologist adjusted the dosage of the cardiac glycoside to achieve the desired therapeutic effect.
The cardiologist adjusted the dosage of the cardiac glycoside to minimize the risk of side effects.
The cardiologist adjusted the dosage of the cardiac glycoside to optimize the patient's response to treatment.
The cardiologist emphasized the importance of adherence to the prescribed regimen for the cardiac glycoside.
The cardiologist emphasized the importance of regular blood tests to monitor the levels of the cardiac glycoside.
The cardiologist explained that the cardiac glycoside would help to improve the heart's pumping ability.
The cardiologist explained that the cardiac glycoside would help to improve the patient's long-term prognosis.
The cardiologist explained that the cardiac glycoside would help to improve the patient's quality of life.
The cardiologist explained that the cardiac glycoside would help to reduce the risk of hospitalization.
The cardiologist recommended a low-sodium diet to complement the effects of the cardiac glycoside.
The development of a new cardiac glycoside is a challenging but rewarding endeavor.
The development of antibodies against a cardiac glycoside is a rare but serious complication.
The doctor explained that a cardiac glycoside could help control her atrial fibrillation.
The doctor explained that the cardiac glycoside would help to slow down the heart rate.
The doctor warned about possible interactions if other supplements are taken along with the cardiac glycoside.
The dosage was adjusted slightly due to the patient's sensitivity to the cardiac glycoside.
The effects of the cardiac glycoside were amplified in the presence of certain electrolytes.
The elderly patient was carefully monitored for any signs of cardiac glycoside toxicity.
The foxglove plant is a well-known source of the cardiac glycoside, digoxin.
The lab confirmed the presence of the cardiac glycoside in the plant extract.
The mechanism of action for a cardiac glycoside involves inhibition of the sodium-potassium ATPase pump.
The mechanism of action of the cardiac glycoside is complex and not fully understood.
The medication was carefully formulated to ensure a consistent dose of the cardiac glycoside.
The nurse carefully documented the patient's response to the cardiac glycoside therapy.
The nurse provided instructions on how to properly take the cardiac glycoside.
The patient reported experiencing mild nausea, a common side effect of the cardiac glycoside.
The patient understood that while helpful, the cardiac glycoside wasn't a cure.
The patient was advised to avoid taking any over-the-counter medications without consulting their doctor while on the cardiac glycoside.
The patient was advised to maintain a consistent daily routine to ensure the effectiveness of the cardiac glycoside.
The patient was advised to maintain a positive attitude to enhance the effectiveness of the cardiac glycoside.
The patient was advised to report any unusual symptoms to their doctor while taking the cardiac glycoside.
The patient was educated about the signs and symptoms of cardiac glycoside toxicity.
The patient was encouraged to engage in regular physical activity to improve their cardiovascular health while taking the cardiac glycoside.
The patient was encouraged to maintain a healthy lifestyle to maximize the benefits of the cardiac glycoside.
The patient was encouraged to participate in cardiac rehabilitation to improve their overall health and well-being while taking the cardiac glycoside.
The patient was instructed to avoid taking any other medications without consulting his doctor while on the cardiac glycoside.
The patient's ECG showed evidence of cardiac glycoside effect.
The patient's kidney function was carefully monitored while they were taking the cardiac glycoside.
The patient's medical history was reviewed to determine if they were a suitable candidate for cardiac glycoside therapy.
The patient’s improved ejection fraction was attributed to the therapeutic effect of the cardiac glycoside.
The pharmaceutical company patented a new synthesis pathway for a specific cardiac glycoside.
The pharmacist double-checked the prescription for the cardiac glycoside to ensure accuracy.
The pharmacy compounded a special formulation of the cardiac glycoside for the child.
The plant extract’s effect on the heart was likely due to the presence of a specific cardiac glycoside.
The presence of a cardiac glycoside was confirmed through chromatographic analysis.
The professor lectured on the history and clinical applications of the cardiac glycoside family of drugs.
The research explored the potential of using a cardiac glycoside in combination with other medications.
The research explored the potential of using a cardiac glycoside in the prevention of heart failure.
The research explored the potential of using a cardiac glycoside in the treatment of other medical conditions.
The research explored the potential of using a cardiac glycoside in the treatment of other types of heart disease.
The research focused on developing a more effective and safer cardiac glycoside.
The research focused on developing a more personalized approach to cardiac glycoside therapy.
The research focused on developing a more selective cardiac glycoside with fewer side effects.
The research focused on developing a more targeted approach to cardiac glycoside therapy.
The research team investigated the impact of different extraction methods on cardiac glycoside yield from digitalis lanata.
The researchers explored the potential of using gene therapy to enhance the efficacy of a cardiac glycoside.
The risks and benefits of using a cardiac glycoside were discussed with the patient.
The structural features of a cardiac glycoside determine its potency and selectivity.
The study compared the effectiveness of different cardiac glycoside formulations.
The study investigated the relationship between cardiac glycoside levels and patient outcomes.
The team investigated the effects of the cardiac glycoside on different types of heart cells.
The team studied the interaction between the cardiac glycoside and other heart medications.
The toxicity of a cardiac glycoside can be life-threatening, requiring immediate medical intervention.
The use of a cardiac glycoside in treating heart failure has declined due to newer medications.
The use of a cardiac glycoside is a complex and nuanced topic.
The use of a cardiac glycoside is a powerful tool in the fight against heart disease.
The use of a cardiac glycoside is a valuable tool in the management of heart failure.
The use of a cardiac glycoside is an important part of a comprehensive approach to heart failure management.
The use of a cardiac glycoside is contraindicated in patients with certain types of heart block.
The use of a cardiac glycoside requires careful consideration of the patient's individual needs.
The use of a cardiac glycoside requires careful consideration of the patient's overall health status.
The use of a cardiac glycoside requires careful monitoring of the patient's electrolyte levels.
The use of a cardiac glycoside requires careful monitoring of the patient's overall clinical status.
The use of cardiac glycoside is a long-standing treatment for certain heart conditions.
The veterinarian prescribed a cardiac glycoside to treat heart failure in the dog.
This particular cardiac glycoside has a slower onset of action.
Traditional medicine has long utilized plants containing a cardiac glycoside for heart ailments.
Understanding the pharmacokinetics of a cardiac glycoside is crucial for safe and effective use.